TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function

Current Biology

Volumn 7, Issue 9, 1997, Pages 652-660

  Loetscher, M ^a   Amara, A ^b   Oberlin, E ^b   Brass, N ^c   Legler, D F ^a   Loetscher, P ^a   D'Apuzzo, M ^a   Meese, E ^c   Rousset, D ^b   Virelizier, J L ^b   Baggiolini, M ^a   Arenzana Seisdedos, F ^b   Moser, B ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b INSTITUT PASTEUR   (France)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 12644278319     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(06)00292-2     Document Type: Article

References (43)

1. Baggiolini M, Dewald B, Moser B: Human chemokines: an update. Annu Rev Immunol 1997, 15:675-705.
2. Moser B, Loetscher M, Piali L, Loetscher P: Lymphocyte responses to chemokines. Intern Rev Immunol 1997, in press.
3. Schall TJ, Bacon KB: Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994, 6:865-873.
4. Gerard C, Gerard NP: The pro-inflammatory seven-transmembrane segment receptors of the leukocyte. Curr Opin Immunol 1994, 6:140-145.
5. Murphy PM: Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Fact Rev 1996, 7:47-64.
6. Fauci AS: Host factors and the pathogenesis of HIV-induced disease. Nature 1996, 384:529-534.
7. D'Souza MP, Harden VA: Chemokines and HIV-1 second receptors - Confluence of two fields generates optimism in AIDS research. Nature Med 1996, 2:1293-1300.
8. Moser B: Chemokines and HIV: a remarkable synergism. Trends in Microbiol 1997, 5:88-90.
9. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
10. Deng HK, Liu R, Ellmeier W, Choe S, Unutmaz D, Burkhart M, et al.: Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996, 381:661-666.
11. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA: CC CKR5: a RANTES, MIP-1 α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996, 272:1955-1958.
12. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, et al.: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996, 85:1135-1148.
13. Doranz BJ, Rucker J, Yi YJ, Smyth RJ, Samson M, Peiper SC, et al: A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996, 85:1149-1158.
14. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR: Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 1997, 185:621-628.
15. Wu LJ, Gerard NP, Wyatt R, Choe H, Parolin C, Ruffing N, et al.: CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 1996, 384:179-183.
16. Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway GP, et al.: CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 1996, 384:184-187.
17. + T cells. Science 1995, 270:1811-1815.
18. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, et al.: The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996, 382:833-835.
19. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996, 382:829-833.
20. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, dark-Lewis I, et al.: Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activated T lymphocytes. J Exp Med 1996, 184:963-969.
21. Kozak M: An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987, 15:8125-8148.
22. Loetscher P, Seitz M, Baggiolini M, Moser B: lnterleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 1996, 184:569-577.
23. Samson M, Soularue P, Vassart G, Parmentier M: The genes encoding the human CC-chemokine receptors CC-CKR1 to CC-CKR5 (CMKBR1-CMKBR5) are clustered in the p21.3-p24 region of chromosome 3. Genomics 1996, 36:522-526.
24. Boulay F, Tardif M, Brouchon L, Vignais P: The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 1990, 29:11123-11133.
25. Gerard NP, Gerard C: The chemotactic receptor for human C5a anaphylatoxin. Nature 1991, 349:614-617.
26. Ames RS, Li Y, Sarau HM, Nuthulaganti P, Foley JJ, Ellis C, et al.: Molecular cloning and characterization of the human anaphylatoxin C3a receptor. J Biol Chem 1996, 271:20231-20234.
27. Nakamura M, Honda Z, Izumi T, Sakanaka C, Mutoh H, Minami M, et al.: Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. J Biol Chem 1991, 266:20400-20405.
28. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 1991, 64:1057-1068.
29. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC: Sequence alignment of the G-protein-coupled receptor superfamily. DNA Cell Biol 1992, 11:1-20.
30. Holmes WE, Lee J, Kuang W-J, Rice GC, Wood WI: Structure and functional expression of a human interleukin-8 receptor. Science 1991, 253:1278-1280.
31. Murphy PM, Tiffany HL: Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 1991, 253:1280-1283.
32. LaRosa GJ, Thomas KM, Kaufmann ME, Mark R, White M, Taylor L, et al.: Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J Biol Chem 1992, 267:25402-25406.
33. Gayle RB, Sleath PR, Srinivason S, Birks CW, Weerawarna KS, Cerretti DP, et al.: Importance of the amino terminus of the interleukin-8 receptor in ligand interactions. J Biol Chem 1993, 268:7283-7289.
34. Suzuki H, Prado GN, Wilkinson N, Navarro J: The N terminus of interleukin-8 (IL-8) receptor confers high affinity binding to human IL-8. J Biol Chem 1994, 269:18263-18266.
35. Ozcelik T, Murphy PM, Francke U: Chromosomal assignment of genes for a formyl peptide receptor (FPR1), a structural homologue of the formyl peptide receptor (FPRL1) and a low affinity interleukin 8 receptor (IL8RA) in human. Cytogenet Cell Genet 1991, 58:2023-2027.
36. Morris SW, Nelson N, Valentine MB, Shapiro DN, Look AT, Kozlosky CJ, et al.: Assignment of the genes encoding human interleukin-8 receptor types 1 and 2 and an interleukin-8 receptor pseudogene to chromosome 2q35. Genomics 1992, 14:685-691.
37. Federsppiel B, Melhado IG, Duncan AMV, Delaney A, Schappert K, dark-Lewis I, Jirik FR: Molecular cloning of the cDNA and chromosomal localization of the gene for a putative seven-transmembrane segment (7-TMS) receptor isolated from human spleen. Genomics 1 993, 16:707-712.
38. Moore JP, Koup RA: Chemoattractants attract HIV researchers. J Exp Med 1996, 184:311-313.
39. Liao F, Alkhatib G, Peden KWC, Sharma G, Berger EA, Farber JM: STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 185:2015-2023.
40. Clark-Lewis I, Moser B, Walz A, Baggiolini M, Scott GJ, Aebersold R: Chemical synthesis, purification, and characterization of two inflammatory proteins, neutrophil activating peptide 1 (interleukin-8) and neutrophil activating peptide 2. Biochemistry 1991, 30:3128-3135.
41. Colotta F, Peri G, Villa A, Mantovani A: Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. J Immunol 1984, 132:936-944.
42. Bachelerie F, Alcami J, Arenzana-Seisdedos F, Virelizier J-L: HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes. Nature 1991, 350:709-712.
43. Jacque J-M, Fernandez B, Arenzana-Seisdedos F, Thomas D, Baleux F, Virelizier J-L, Bachelerie F: Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-κB is needed for persistent viral replication in monocytes. J Virol 1996, 70:2930-2938.